Endocr Pract. 2018 Apr;24(4):321-328. doi: 10.4158/EP-2017-0221. Epub 2018 Mar 21.
To identify provider recommendations and barriers in obesity management in a multicenter academic health system with extensive weight-loss management resources.
A 26-question online survey was sent to attending physicians, trainees, and advanced practice providers in primary care specialties (internal medicine, family medicine, women's health) and endocrinology.
The survey response rate was 26% (111/430). Of respondents, 50% were internal medicine, 24% family medicine, 16% women's health, and 9% endocrinology. The majority were attending physicians (54%) and residents (40%). About 50% of respondents advised weight loss for a body mass index (BMI) >30 kg/m in >50% of clinic visits. Limited time (82%) was the most common reason for not discussing weight loss, followed by the perception that discussion would not change patient behavior, insufficient knowledge, and discomfort broaching the subject. Common barriers to prescribing anti-obesity medications included limited experience (57%) and concern for adverse reactions (26%). Only 44% offered bariatric surgery to >50% of their patients who met criteria. Primary reasons for not referring included concerns of high surgical risk from comorbidities (57%) and potential adverse events (32%). Endocrinology had the highest referral to surgery. Attending physicians and fellows were more likely than residents to advise weight loss at lower BMI, offer medications, and refer to bariatric surgery.
Our study reveals reluctance and lack of primary care confidence in managing obesity with pharmacotherapy and bariatric surgery, especially in the earlier stages of obesity. Barriers to care include lack of clinic time, limited experience, and concerns about treatment risks.
BMI = body mass index; HbA1c = hemoglobin A1c; IRB = Institutional Review Board.
在一个拥有广泛减重管理资源的多中心学术医疗系统中,确定在肥胖管理方面的提供者建议和障碍。
向初级保健专业(内科、家庭医学、妇女健康)和内分泌学的主治医生、住院医师和高级实践提供者发送了一份包含 26 个问题的在线调查。
调查回复率为 26%(111/430)。受访者中,50%为内科医生,24%为家庭医生,16%为妇女健康医生,9%为内分泌医生。大多数为主治医生(54%)和住院医师(40%)。约 50%的受访者建议对 BMI >30 kg/m2 的患者在超过 50%的就诊中进行减重。不讨论减重的最常见原因是时间有限(82%),其次是认为讨论不会改变患者行为、知识不足和不愿提及该主题。开具抗肥胖药物的常见障碍包括经验有限(57%)和担心不良反应(26%)。只有 44%的医生向符合标准的超过 50%的患者提供减重手术。不转介的主要原因包括对合并症(57%)和潜在不良事件(32%)引起的高手术风险的担忧。内分泌科转介手术的比例最高。主治医生和研究员比住院医师更有可能在 BMI 较低时建议减重、提供药物并转介进行减重手术。
我们的研究表明,初级保健医生在使用药物治疗和减重手术治疗肥胖方面存在不情愿和缺乏信心,尤其是在肥胖的早期阶段。治疗障碍包括缺乏就诊时间、经验有限和对治疗风险的担忧。
BMI = 体重指数;HbA1c = 糖化血红蛋白;IRB = 机构审查委员会。